Insight
Study
M&A strategies for specialty-chemical corporates
How can specialty-chemical corporates increase their total shareholder return? Our study provides insight into the industry’s recipe for successful M&A activities. The key takeaways: a) Go small. Corporates with low deal volume focus achieved significantly higher average annual TSR (14,3%) compared to corporates with high deal volume focus (TSR: 5,9%). b) Leverage private equity’s sustained interest in chemical M&A.
Strategy and Growth
Portfolio Strategy and Buy & Build
Industrials and Automotive
Healthcare and Life Sciences

Scroll down
ContactGet in touch

Dr. Gerrit Schütte
Due Diligence, Value Creation and Exit Readiness, Portfolio Strategy and Buy & Build, Principal Investors and Private Equity, Industrials and Automotive